Lanean...
The treatment of mitral insufficiency in refractory heart failure
Secondary mitral insufficiency (SMI) is caused by dilatation and left ventricular dysfunction and is a frequent finding in patients with heart failure (HF). It is associated with a mortality of between 40% and 50% at 3 years. The first-line treatment is represented by medical therapy, possibly assoc...
Gorde:
| Argitaratua izan da: | Eur Heart J Suppl |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904083/ https://ncbi.nlm.nih.gov/pubmed/33654472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa143 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|